SPY424.31+0.70 0.17%
DIA345.12+0.14 0.04%
IXIC14,069.42+49.09 0.35%

BRIEF-G1 Therapeutics Initiates Phase 2 Study Of COSELA

05/10/2021 07:45
BRIEF-G1 Therapeutics Initiates Phase 2 Study Of COSELA

- G1 Therapeutics Inc GTHX.O:

  • G1 THERAPEUTICS INITIATES RANDOMIZED DOUBLE BLIND PLACEBO CONTROLLED PHASE 2 STUDY OF COSELA™ (TRILACICLIB) IN NON-SMALL CELL LUNG CANCER (PRESERVE 4)

  • G1 THERAPEUTICS INC - RESULTS OF STUDY ARE EXPECTED IN FIRST HALF OF 2023.

Source text for Eikon: ID:nGNX6fStYr

Further company coverage: GTHX.O


(([email protected];))